New Antibiotic For Bacterial Pneumonia And Skin Infections Not Inferior To Current Treatments, FDA Staff Reviewers Say.

August 07, 2018

Reuters (8/6, Mathias) reports, “Paratek Pharmaceuticals Inc.’s new antibiotic” omadacycline “for bacterial pneumonia and skin infections is not inferior to current treatments, U.S. Food and Drug Administration staff reviewers said on Monday.” The drug w...